Omnicell Common Stock Net 2010-2025 | OMCL
Omnicell common stock net from 2010 to 2025. Common stock net can be defined as the value of common equity ownership.
| Omnicell Annual Common Stock Net (Millions of US $) |
|
|---|---|
| 2024 | $0 |
| 2023 | $0 |
| 2022 | $0 |
| 2021 | $0 |
| 2020 | $0 |
| 2019 | $0 |
| 2018 | $0 |
| 2017 | $0 |
| 2016 | $0 |
| 2015 | $0 |
| 2014 | $0 |
| 2013 | $0 |
| 2012 | $0 |
| 2011 | $0 |
| 2010 | $0 |
| 2009 | $0 |
| Omnicell Quarterly Common Stock Net (Millions of US $) |
|
|---|---|
| 2025-03-31 | $0 |
| 2024-12-31 | $0 |
| 2024-09-30 | $0 |
| 2024-06-30 | $0 |
| 2024-03-31 | $0 |
| 2023-12-31 | $0 |
| 2023-09-30 | $0 |
| 2023-06-30 | $0 |
| 2023-03-31 | $0 |
| 2022-12-31 | $0 |
| 2022-09-30 | $0 |
| 2022-06-30 | $0 |
| 2022-03-31 | $0 |
| 2021-12-31 | $0 |
| 2021-09-30 | $0 |
| 2021-06-30 | $0 |
| 2021-03-31 | $0 |
| 2020-12-31 | $0 |
| 2020-09-30 | $0 |
| 2020-06-30 | $0 |
| 2020-03-31 | $0 |
| 2019-12-31 | $0 |
| 2019-09-30 | $0 |
| 2019-06-30 | $0 |
| 2019-03-31 | $0 |
| 2018-12-31 | $0 |
| 2018-09-30 | $0 |
| 2018-06-30 | $0 |
| 2018-03-31 | $0 |
| 2017-12-31 | $0 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| 2016-09-30 | $0 |
| 2016-06-30 | $0 |
| 2016-03-31 | $0 |
| 2015-12-31 | $0 |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2015-03-31 | $0 |
| 2014-12-31 | $0 |
| 2014-09-30 | |
| 2014-06-30 | |
| 2014-03-31 | |
| 2013-12-31 | $0 |
| 2013-09-30 | |
| 2013-06-30 | |
| 2013-03-31 | |
| 2012-12-31 | $0 |
| 2012-09-30 | |
| 2012-06-30 | |
| 2012-03-31 | |
| 2011-12-31 | $0 |
| 2011-09-30 | |
| 2011-06-30 | |
| 2011-03-31 | |
| 2010-12-31 | $0 |
| 2010-09-30 | |
| 2010-06-30 | |
| 2010-03-31 | |
| 2009-12-31 | $0 |
| 2009-09-30 | |
| 2009-06-30 | |
| 2009-03-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $1.429B | $1.112B |
| Omnicell Inc., develops and markets end-to-end automation solutions for the medication-use process. These automation solutions contain medication and supply dispensing systems, central pharmacy storage, retrieval and packaging solutions, a bedside automation solution, a physician order management solution, a decision support application, and a Web-based procurement application. The products offered by the company enable care providers to improve patient safety and increase efficiency by lowering costs. The company also adheres to regulatory compliances and addresses issues related to population health. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $45.994B | 58.52 |
| Hims & Hers Health (HIMS) | United States | $12.427B | 102.82 |
| Doximity (DOCS) | United States | $10.881B | 50.37 |
| Tempus AI (TEM) | United States | $9.996B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $5.151B | 0.00 |
| Hinge Health (HNGE) | United States | $3.762B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.600B | 38.22 |
| Privia Health (PRVA) | United States | $2.371B | 162.08 |
| 10x Genomics (TXG) | United States | $1.639B | 0.00 |
| Phreesia (PHR) | United States | $1.613B | 0.00 |
| Enovis (ENOV) | United States | $1.511B | 8.43 |
| Clover Health Investments (CLOV) | United States | $1.450B | 0.00 |
| Schrodinger (SDGR) | United States | $1.441B | 0.00 |
| Azenta (AZTA) | United States | $1.231B | 53.80 |
| Evolent Health (EVH) | United States | $1.115B | 95.00 |
| Claritev (CTEV) | United States | $0.650B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.636B | 0.00 |
| Veradigm (MDRX) | United States | $0.514B | 0.00 |
| Standard BioTools (LAB) | United States | $0.494B | 0.00 |
| Talkspace (TALK) | United States | $0.380B | 113.50 |
| Zepp Health (ZEPP) | Netherlands | $0.349B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.336B | 0.00 |
| Carlsmed (CARL) | $0.325B | 0.00 | |
| TruBridge (TBRG) | United States | $0.314B | 696.33 |
| Health Catalyst (HCAT) | United States | $0.266B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.254B | 0.00 |
| Outset Medical (OM) | United States | $0.250B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.228B | 0.00 |
| CapsoVision (CV) | United States | $0.192B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.151B | 0.00 |
| American Well (AMWL) | United States | $0.132B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.118B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.113B | 0.00 |
| CareCloud (CCLD) | United States | $0.101B | 4.58 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.084B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.075B | 0.00 |
| Pulmonx (LUNG) | United States | $0.067B | 0.00 |
| 111 (YI) | China | $0.059B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.050B | 0.00 |
| HeartBeam (BEAT) | United States | $0.034B | 0.00 |
| Zhongchao (ZCMD) | China | $0.024B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.023B | 0.00 |
| Precipio (PRPO) | United States | $0.022B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.013B | 0.00 |
| HeartSciences (HSCS) | United States | $0.008B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.008B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.008B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.007B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.007B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.005B | 0.00 |
| Movano (MOVE) | United States | $0.004B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.004B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.004B | 0.00 |
| PROFUSA (PFSA) | United States | $0.003B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |